About this Webinar Series
Wednesday, February 10, 2020; 12:00 PM – 3:00 PM ET
Employers have long realized the various impacts that chronic diseases can have on individuals within their workforce – both from an HR perspective and a medical-cost perspective. And while the pandemic has both exacerbated and underscored the importance of chronic condition management, many HR and benefits teams were forced to hit the pause button or say ‘not yet’ with some of the innovations and launches that may have been planned and re-prioritize where focus needs to lie. In this webinar series, we discuss the chronic conditions that most impact employers from a cost and productivity perspective, examine current thinking in regards to benefit offerings in this new Covid-world, and share insights and recommendations to best address the impact of chronic conditions on the workforce.
This webinar is co-hosted by World Congress and Validation Institute.
12:00 – 1:00 PM
Employer Perspectives: Strategies and Approaches to Disease Prevention, Monitoring, and Management in 2021
This panel of HR and Benefits executives shares their insights and experience in helping their employees affected by chronic conditions achieve better health outcomes – knowing healthy employees are more productive employees – while lowering health care costs for their organization through the prevention and management of chronic diseases. Knowing that the pandemic has both exacerbated and underscored the importance of chronic condition management, hear about different considerations, approaches, and strategies being evaluated in 2021.
- Understand the risks those with chronic diseases face during the pandemic and steps employers can take now to help
- Discuss various discovery methods for employees to better understand their status with disease and what their own data could tell them to become better stewards of their own health
- Identify the types of programs that have traditionally led to the most impactful results – from cost-savings to employee well-being and satisfaction – and what may be the same or different during, and after, the pandemic
- Examine best practices to implementing disease prevention, monitoring, and management programs as a part of your benefit offerings
- Learn strategies to overcome common engagement struggles, such as providing incentives to drive behavior change and/or disincentives for inaction
1:00 – 2:00 PM
Evaluate the Impact of Osteoarthritis on Employers
Osteoarthritis (OA), the most common form of arthritis, affects more than 32.5 million US adults, according to the CDC. OA can cause pain, stiffness, and swelling, and usually develops slowly, but gets worse over time, the CDC continues, yet there is no cure. Since OA is more prevalent in the working age population, and a significant portion of individuals with OA have a moderate to severe condition, OA impacts workers’ productivity, as well as an organization’s direct health care costs, and disability. This panel examines why employers and other plan sponsors should be aware of the impact of osteoarthritis (OA) on their workforce, and considerations those charged with managing employee benefits should take into account.
- Gain a better understanding of disease, such as what OA is, what causes OA, and the risk factors that may lead to OA
- Examine the effects OA can have on workers – From productivity, to absenteeism, and more
- Discuss the current options available for managing the pain of OA – Nonpharmacologic, pharmacotherapy, and surgery
- Consider the effectiveness, appropriateness, and/or tolerability of current options and where unmet needs may still exist
- Identify the key considerations HR and benefits teams should take into account when evaluating the impact of OE on their business and workforce
Brian Gifford, PhD
Director, Research and Analytics
Integrated Benefits Institute
Heather Sell, PharmD, BCPS
Director, National Employer Medical Outcomes Specialist
Vice President, Enterprise Growth Strategy
2:00 – 3:00 PM
In Association with:
It’s an audacious, incredibly rewarding mission that our team is dedicated to achieving.
EmpiRx Health is built on the idea that the time has come for value-based care in the pharmacy benefits industry. It’s time to break the status quo of volume-based rebates and discounts that do nothing to help people. We believe there is a better way. We believe in improving health outcomes while lowering costs by using the right clinical and financial strategies.
Established in 2012, the Greater Philadelphia Business Coalition on Health (GPBCH) is a membership organization open to any employer that is corporately based or that has a significantly employed population in our service area. The Coalition’s service area includes the Philadelphia five-county region (Philadelphia, Bucks, Montgomery, Chester, and Delaware Counties), the State of Delaware, and Southern New Jersey (Camden, Burlington, Gloucester, Salem, Cumberland, Atlantic and Cape May Counties). GPBCH also offers affiliate memberships to organizations that do not participate as employers but have an interest in supporting GPBCH’s mission.
Our mission is to increase the value of health benefit spending for employer members, by improving workforce and community health, increasing healthcare quality and safety, and reducing health care costs. The Coalition represents employer interests in working with health plans, health care providers, benefits consultants, suppliers and other system stakeholders to address population health priorities and to ensure that when health care is needed it is accessible, affordable, high-quality, and safe.
GPBCH is one of more than 50 business coalitions that collaborate through the National Alliance of Healthcare Purchaser Coalitions to influence national policy and to share expertise and best practices.
Click the link below for more information.
Greater Philadelphia Business Coalition on Health (GPBCH) Profile.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.pfizer.com. In addition, to learn more, please visit us on www.pfizer.com and follow us on Twitter at @Pfizer and @Pfizer_News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.